Decisions 28th November 2017


 

At the meeting on the 28th November the following decisions were agreed

New Drug Requests

Approved

Ulipristal (TLS green)    

 

  • Approved for inclusion onto the formulary for hormal emergency contraception

Ganciclovir eye gel (TLS blue)

  • Approved for inclusion onto the formulary for acute herpetic keratitis

Ceftazidime/avibactam (TLS Red)

    • Approved for inclusion onto the formulary on the advice of microbiology for proven multi-drug resistant gram-negative pathogens most likely carbapenem resistant enterobacteriaceae due to KPC or OXA-48 B.lactamases. 

    Betnesol-N (TLS green)  

     

    • Approved for inclusion onto the formulary for treatment of otitis externa

    Shared Care Protocols/TLS change in Status

     

    Degarelix

     

    • New SCP, clarification regarding monitoring required

     

    Dymista

     

    • Further information required for change TLS amber to green

     

    Lidocaine 5%  transdermal Patch (TLS Red to Amber)


    • Change of TLS from red to amber (No SCP) agreed
       

    Cabergoline and bromocriptine

    • New SCP, approved

    Penicillamine

    • Updated SCP and advise sheet approved

    Gold

    • Updated SCP and advise sheet approved

    Other

    Iron preparations

    • JFG agreed that trusts can decide locally on which preparation are the most cost effective to use in specific clinical situations.

     

     

     



     

    Last updated by: Emily Knight on 05-02-2018 14:58